arrow
M

Mandy L. Ballinger

Garvan Institute of Medical Research
H指数:31
被引数:3,482

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tucatinib and trastuzumab in advanced cancers with HER2 mutations or amplifications: a molecular screening and therapeutics (MoST) program substudy

Tucatinib和曲妥珠单抗在HER2突变或扩增的晚期癌症中的研究:分子筛查和治疗(MoST)计划子研究

2026-07-240
OA
Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS (LUMOS2) study

低级别和间级别胶质瘤伞式研究:分子指导疗法(LUMOS2)研究

2025-11-010
OAAI
Implementation of precision medicine in treating non-communicable diseases: a systematic review

在非传染性疾病治疗中实施精准医学:一项系统综述

2025-10-280
OAAI
Integration of precision medicine into routine cancer care-protocol for the Precision Care Initiative: a research programme of effectiveness-implementation hybrid trials

将精准医疗整合到常规癌症护理中的方案——精准护理倡议的协议:一项效果-实施混合试验的研究计划

2025-10-150
OA
Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)

症状和功能负担对胰腺导管腺癌(PDAC)生存期的影响

2024-09-010
PRE
Tucatinib and trastuzumab in advanced cancers with HER2 mutations or amplification: A molecular screening and therapeutics (MoST) program substudy

Tucatinib和Trastuzumab在HER2突变或扩增的晚期癌症中的应用:一项分子筛查与治疗(MoST)计划亚研究

2024-09-010
PRE
Underlying germline genetic architecture of pediatric sarcomas: Evaluating the role of common and rare variants in 4,160 patients
2024-03-220
PRE
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue

抽吸: 转移性肺癌组织中全面基因组分析的澳大利亚观察性队列研究

2023-09-281
OA